Can large-scale trials or meta-analyses demonstrate blood pressure-independent effect of angiotensin receptor blockers? [4]

Hypertension

Volumn 50, Issue 4, 2007, Pages

  Minami, Junichi ^a   Ishimitsu, Toshihiko ^a   Matsuok, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; CANDESARTAN; CHLORTALIDONE; EPROSARTAN; LISINOPRIL; LOSARTAN; NITRENDIPINE; TELMISARTAN; VALSARTAN;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; HYPERTENSION; LETTER; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; HUMANS; HYPERTENSION; META-ANALYSIS; MYOCARDIAL INFARCTION; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 34548864105     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.097402     Document Type: Letter

References (2)

1. Wang JG, Li Y, Franklin SS, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview. Hypertension. 2007;50:181-188.
2. Minami J, Ishimitsu T, Matsuoka H. Levels of plasma renin activity before treatment and therapeutic response to telmisartan in essential hypertension. Am J Hypertens. In press.